Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care
Open accessThe DOI matches its Crossref record; 196 of the 197 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To assess the accuracy in diagnosing heart failure of clinical features and potential primary care investigations, and to perform a decision analysis to test the impact of plausible diagnostic strategies on costs and diagnostic yield in the UK health-care setting. DATA SOURCES: MEDLINE and CINAHL were searched from inception to 7 July 2006. 'Grey literature' databases and conference proceedings were searched and authors of relevant studies contacted for data that could not be extracted from the published papers. REVIEW METHODS: A systematic review of the clinical evidence was carried out according to standard methods. Individual patient data (IPD) analysis was performed on nine studies, and a logistic regression model to predict heart failure was developed on one of the data sets and validated on the other data sets. Cost-effectiveness modelling was based on a decision tree that compared different plausible investigation strategies. RESULTS: Dyspnoea was the only symptom or sign with high sensitivity (89%), but it had poor specificity (51%). Clinical features with relatively high specificity included history of myocardial infarction (89%), orthopnoea (89%), oedema (72%), elevated jugular venous pressure (70%), cardiomegaly (85%), added heart sounds (99%), lung crepitations (81%) and hepatomegaly (97%). However, the sensitivity of these features was low, ranging from 11% (added heart sounds) to 53% (oedema). Electrocardiography (ECG), B-type natriuretic peptides (BNP) and N-terminal pro-B-type natriuretic peptides (NT-proBNP) all had high sensitivities (89%, 93% and 93% respectively). Chest X-ray was moderately specific (76-83%) but insensitive (67-68%). BNP was more accurate than ECG, with a relative diagnostic odds ratio of ECG/BNP of 0.32 (95% CI 0.12-0.87). There was no difference between the diagnostic accuracy of BNP and NT-proBNP. A model based upon simple clinical features and BNP derived from one data set was found to have good validity when applied to other data sets. A model substituting ECG for BNP was less predictive. From this a simple clinical rule was developed: in a patient presenting with symptoms such as breathlessness in whom heart failure is suspected, refer directly to echocardiography if the patient has a history of myocardial infarction or basal crepitations or is a male with ankle oedema; otherwise, carry out a BNP test and refer for echocardiography depending on the results of the test. On the basis of the cost-effectiveness analysis carried out, such a decision rule is likely to be considered cost-effective to the NHS in terms of cost per additional case detected. The cost-effectiveness analysis further suggested that, if likely benefit to the patient in terms of improved life expectancy is taken into account, the optimum strategy would be to refer all patients with symptoms suggestive of heart failure directly for echocardiography. CONCLUSIONS: The analysis suggests the need for important changes to the NICE recommendations. First, BNP (or NT-proBNP) should be recommended over ECG and, second, some patients should be referred straight for echocardiography without undergoing any preliminary investigation. Future work should include evaluation of the clinical rule described above in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, dapagliflozin reduced all-cause mortality (HR 0.83; 95% CI, 0.71-0.97)and improved symptoms, physical function, and quality of life in patients with HFrEF.491,492”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [491]
Experimental — accuracy not yet measuredIn the citing paper
“Therapy with dapagliflozin 10 mg o.d. vs. placebo reduced the risk of the primary outcome, a composite of worsening HF (hospitalization or an urgent visit resulting in i.v.therapy for HF) or CV death, by 26% (HR 0.74; 95% CI, 0.65-0.85).”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [491]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
Maisel, A. S., Krishnaswamy, P., Nowak, R. M., McCord, J., Hollander, J. E., Duc, P., Omland, T., Storrow, A. B., Abraham, W. T., Wu, A. H. B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020233 · Cited by 3,362
The effect of digoxin on mortality and morbidity in patients with heart failure
(1997) · New England Journal of Medicine · doi:10.1056/nejm199702203360801 · Cited by 3,016
Research works printed but not linked: 2
- AJ. Should general practitioners use the electrocardiogram to select patients with suspected heart failure for echocardiography? Int J Cardiol 1997;62:31–6.
- X-ray, radionuclide ventriculography and right heart catheterization. Eur Heart J 1989;10:1017–28.
Cited by
Items 201–300 of 510
Siwik, D., Apanasiewicz, W., Żukowska, M., Jaczewski, G., & Dąbrowska, M. (2023) · Advances in respiratory medicine · doi:10.3390/arm91020010 · Cited by 22
“A systematic review emphasised its moderate to high specificity (76–83%) but lower sensitivity (67– 68%) in HF diagnosis [17].”
BackgroundGc, V. S., Suhrcke, M., Atkin, A. J., van Sluijs, E. M. F., & Turner, D. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027566 · Cited by 26
Jonsson, Å., Orwelius, L., Dahlström, U., & Kristenson, M. (2020) · Journal of Patient-Reported Outcomes · doi:10.1186/s41687-020-00216-7 · Cited by 21
Nguyen, T.-P.-L., Nguyen, T. T., Nguyen, T. T., Hac, V. V., Le, H. H., Schuiling‐Veninga, C. C. M., & Postma, M. J. (2014) · BMC Health Services Research · doi:10.1186/s12913-014-0514-4 · Cited by 20
NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact study
Fonseca, C., Bettencourt, P., Brito, D. A., Febra, H., Pereira, Á. A., Genovez, V., & Lopes, N. (2021) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.03.009 · Cited by 19
Cost Effectiveness of Prostacyclins in Pulmonary Arterial Hypertension
Román, A., Barberà, J. A., Escribano, P., Sala, M. L., Febrer, L., Oyagüez, I., Cabrera, E. S., & Casado, M. Á. (2012) · Applied Health Economics and Health Policy · doi:10.2165/11630780-000000000-00000 · Cited by 19
Kangaroo Mother Care 20 Years Later: Connecting Infants and Families
Furman, L. (2017) · PEDIATRICS · doi:10.1542/peds.2016-3332 · Cited by 24
Hussey, L. J., Stocks, S. J., Wilson, P. M., Dumville, J. C., & Cullum, N. A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028727 · Cited by 19
Exploration of Potential Genetic Biomarkers for Heart Failure: A Systematic Review
Chair, S. Y., Chan, J. Y., Waye, M. M. Y., Liu, T., Law, B. M. H., & Chien, W. T. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18115904 · Cited by 20
Whitty, J. A., Ratcliffe, J., Kendall, E. A., Burton, P., Wilson, A. J., Littlejohns, P., Harris, P., Krinks, R., & Scuffham, P. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008919 · Cited by 20
Steinmann, E., Rocca, H. B., Maeder, M. T., Kaufmann, B. A., Pfisterer, M. E., & Rickenbacher, P. R. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.06.005 · Cited by 19
Klassen, A. F., van Haren, E. L. W. G., Cross, K., Fan, K. L., Sidey-Gibbons, C. J., Hoogbergen, M. M., Longmire, N. M., Poulsen, L., Sørensen, J. A., Squitieri, L., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-032332 · Cited by 19
Lin, Y., Zhang, L., Hu, X., Gao, L., Ji, M., He, Q., Xie, M., & Li, Y. (2023) · Diagnostics · doi:10.3390/diagnostics13182923 · Cited by 19
Client perspectives on choice of abortion method in England and Wales
Blaylock, R., Makleff, S., Whitehouse, K., & Lohr, P. A. (2021) · BMJ Sexual & Reproductive Health · doi:10.1136/bmjsrh-2021-201242 · Cited by 18
Giordano, N., Rosati, S., & Knaflitz, M. (2021) · Sensors · doi:10.3390/s21217246 · Cited by 18
“It is well known that each acute episode significantly compromises the life expectance of the patient [24,25].”
BackgroundObesity: Only half of England has access to comprehensive weight loss services
Mahase, E. (2024) · BMJ · doi:10.1136/bmj.q1950 · Cited by 18
Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024
Chinese Society of Cardiology, C. M. A., Chinese College of Cardiovascular Physician, Chinese Heart Failure Association of Chinese Medical Doctor Association, & Editorial Board of Chinese Journal of Cardiology (2025) · Cardiology Discovery · doi:10.1097/cd9.0000000000000146 · Cited by 49
Gils, C., Ramanathan, R., Breindahl, T., Brokner, M., Christiansen, A. L., Eng, Ø., Hammer, I. J., Herrera, C. B., Jansen, A., Langsjøen, E. C., et al. (2015) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1066846 · Cited by 17
Severo, M., Gaio, R., Lourenço, P., Alvelos, M., Gonçalves, A., Lunet, N., Bettencourt, P., & Azevedo, A. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001510 · Cited by 21
Ask the right question: a critical step for practicing evidence-based laboratory medicine
Price, C. P., & Christenson, R. H. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213476486 · Cited by 17
“natriuretic peptide levels in breathless patients).(29) Similarly results may vary according to gender, age or lifestyle.”
ResultCuriati, M. N. C., Silvestre, O. M., Pires, L. J. T., Mangini, S., Pires, P. V., Gaiotto, F. A., Laurino, A. M., Pêgo‐Fernandes, P. M., Ferreira, C. E. D. S., & Bacal, F. (2013) · Einstein (São Paulo) · doi:10.1590/s1679-45082013000300003 · Cited by 17
“2013;11(3):273-7 multiple linear regression was used.”
BackgroundInfluentialInformation needs among women taking part in primary HPV screening in England: a content analysis
Marlow, L. A. V., Forster, A. S., McBride, E., Rockliffe, L., Kitchener, H. C., & Waller, J. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-044630 · Cited by 19
ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
Aspromonte, N., Gulizia, M. M., Clerico, A., Tano, G. D., Emdin, M., Feola, M., Iacoviello, M., Latini, R., Mortara, A., Valle, R., et al. (2017) · European Heart Journal Supplements · doi:10.1093/eurheartj/sux027 · Cited by 17
Anguita, M. P., Bayés‐Genís, A., Cepeda, J. M., Cinza‐Sanjurjo, S., Cosín, J., Leiro, M. C., Egocheaga, I., Escobar, C., Faraudo, M., García-Pinilla, J. M., et al. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30016-9 · Cited by 24
“Baja calidad RR = 0,68 (IC95%, 0,50-0,92); I2 = 48%; NNT = 11 [7-44]e”
The role of imaging in characterizing the cardiac natural history of Duchenne muscular dystrophy
Lee, S., Lee, M., & Hor, K. N. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25227 · Cited by 16
Bugge, C., Sæther, E. M., Pahle, A., Halvorsen, S., & Kristiansen, I. S. (2018) · BJGP Open · doi:10.3399/bjgpopen18x101596 · Cited by 16
“The results of previous studies indicate that the use of natriuretic peptides is cost effective, 8,9 but none of the studies encompassed the use of POC in general practice when diagnosing HF. 8 Mant et al state that ’future work should include evaluation of the clinical decision rule [NT-proBNP and…”
ResultCampbell, S., Fuat, A., Summerton, N., Lancaster, N., & Hobbs, R. F. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x583218 · Cited by 16
Pillai, M., Welsh, V., Sedgeman, K., Gazet, A. C., Staddon, J., & Carter, H. (2014) · Journal of Family Planning and Reproductive Health Care · doi:10.1136/jfprhc-2013-100700 · Cited by 17
Knight, H., Harman, D., Morling, J. R., Aithal, G. P., Card, T. R., Guha, I. N., & Bains, M. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041574 · Cited by 16
Beta-Blockers and Ivabradine in Chronic Heart Failure: From Clinical Trials to Clinical Practice
Franco, A. D., Sarullo, F. M., Salerno, Y., Figliozzi, S., Parrinello, R., Pasquale, P. D., & Lanza, G. A. (2013) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-013-0057-9 · Cited by 16
Dayya, D., O’Neill, O., Habib, N., Moore, J. L., Iyer, K., & Huedo-Medina, T. B. (2022) · BMJ Surgery Interventions & Health Technologies · doi:10.1136/bmjsit-2021-000081 · Cited by 15
Rice, D. B., Kloda, L. A., Shrier, I., & Thombs, B. D. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012867 · Cited by 16
Role of B-type natriuretic peptide (BNP) in heart failure
Uddin, M. H., Rashid, T., & Chowdhury, S. M. (2016) · International Journal on Disability and Human Development · doi:10.1515/ijdhd-2015-0021 · Cited by 16
“Table 4: Overall accuracy of investigations of heart failure [22].”
BackgroundChambers, D., Booth, A., Baxter, S. K., Johnson, M., Dickinson, K. C., & Goyder, E. (2016) · Health Services and Delivery Research · doi:10.3310/hsdr04350 · Cited by 18
“The HTA report also highlighted that the utility of BNP testing will depend on the pre-test probability of chronic heart failure in the patient.(79) BNP testing would contribute important diagnostic information, as a negative test would reduce the post-test probability.”
BackgroundMethodInfluentialMcBride, E., Marlow, L. A. V., Forster, A. S., Moss, S., Myles, J. P., Kitchener, H. C., Patnick, J., & Waller, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-014356 · Cited by 15
Characterisation of the patients with suspected heart failure: experience from the SHEAF registry
Garg, P., Dakshi, A., Assadi, H. S., Swift, A. J., Naveed, U., Fent, G. J., Lewis, N. T., Rogers, D. P. S., Charalampopoulos, A. F., & Al‐Mohammad, A. (2021) · Open Heart · doi:10.1136/openhrt-2020-001448 · Cited by 15
Monahan, M., Barton, P. M., Taylor, C. J., Roalfe, A. K., Hobbs, R. F., Cowie, M., Davis, R., Deeks, J. J., Mant, J., McCahon, D., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.02.149 · Cited by 15
“The methodology behind the benefits of each strategy was drawn largely from a previous HF Health Technology Assessment (HTA) report.(9) We assumed a confirmed HF diagnosis leads to patients being initiated on HF drug treatment if they have HF with Reduced Ejection Fraction (HFREF).”
BackgroundMethodInfluentialSelf-citationChronic heart failure: New challenges and new perspectives
Tereshchenko, S. N., & Жиров, И. В. (2017) · Terapevticheskii arkhiv · doi:10.17116/terarkh20178994-9 · Cited by 15
Prevalence and treatment of heart failure in Swedish nursing homes
Bolmsjö, B. B., Mölstad, S., Östgren, C. J., & Midlöv, P. (2013) · BMC Geriatrics · doi:10.1186/1471-2318-13-118 · Cited by 14
“Quantitative analysis of plasma concentrations of BNP is useful to help confirming the diagnosis, provide a prognosis and guide treatment in patients with HF [4,13].”
BackgroundSim, D., Lin, W., Sindone, A. P., Yingchoncharoen, T., Prameswari, H. S., Ghazi, A. M., Pin, L. C., Teo, L. L. Y., Aw, T. C., Agbayani, M. F., et al. (2023) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2022.42 · Cited by 14
Tait, L., Roalfe, A. K., Mant, J., Cowie, M., Deeks, J. J., Iles, R., Barton, P. M., Taylor, C. J., Derit, M., & Hobbs, R. F. (2012) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-12-97 · Cited by 18
“A major problem with all the studies we uncovered in our review of the diagnostic test systematic reviews is spectrum and referral bias since most were based on observational screening studies rather than symptomatic presenting patients, and some were hospital rather than community based [40].”
BackgroundMethodInfluentialSelf-citationBingisser, R. M., Cairns, C. B., Christ, M., Collinson, P. O., Hausfater, P., Lindahl, B., Mair, J., Price, C. P., & Venge, P. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.012 · Cited by 15
Hudson, C. D., Huxley, J. N., & Green, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103426 · Cited by 14
Assessment of Manual Workload Limits in Gynecologic Cytology
Renshaw, A. A., & Elsheikh, T. M. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcp23ydfkkqnuao · Cited by 14
Adolescent ecstasy use and depression: cause and effect, or two outcomes of home environment?
McCann, M., Higgins, K., Perra, O., McCartan, C. J., & McLaughlin, A. (2014) · European Journal of Public Health · doi:10.1093/eurpub/cku062 · Cited by 14
Management Considerations in the Care of Elderly Heart Failure Patients in long-term Care Facilities
Heckman, G. A., Boscart, V., & McKelvie, R. S. (2014) · Future Cardiology · doi:10.2217/fca.14.35 · Cited by 14
Colao, A., Lucchese, M., D’Adamo, M., Savastano, S., Facchiano, E., Veronesi, C., Blini, V., Esposti, L. D., & Sbraccia, P. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013899 · Cited by 14
Chaudhary, R., Sukhi, A., Simon, M. A. M., Villanueva, F. S., & Pacella, J. J. (2021) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2021.08.009 · Cited by 14
Miller, M. H., Fraser, A. G., Leggett, G., MacGilchrist, A., Gibson, G., Orr, J. G., Forrest, E. H., Dow, E., Bartlett, W. A., Weatherburn, C., et al. (2018) · Frontline Gastroenterology · doi:10.1136/flgastro-2017-100909 · Cited by 14
Is echocardiography mandatory for patients with chronic kidney disease?
Nardi, E., Mulè, G., Nardi, C., Geraci, G., Giammanco, A., Bentivegna, R., & Averna, M. R. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02028-0 · Cited by 15
Anokye, N., Coyle, K., Relton, C., Walters, S. J., Strong, M., & Fox-Rushby, J. A. (2019) · Archives of Disease in Childhood · doi:10.1136/archdischild-2018-316741 · Cited by 15
Andersson, E., Ydrefelt, Y. D., Johannesson, M., Lundbäck, M., Mannila, M. N., Persson, M., Swahn, E., & Bolejko, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-048721 · Cited by 15
Diagnosing Heart Failure – Experience and ‘Best Pathways’
Taylor, C. J., & Hobbs, R. F. (2010) · European Cardiology Review · doi:10.15420/ecr.2010.6.3.10 · Cited by 13
Charman, S. J., Okwose, N. C., Stefanetti, R. J., Bailey, K. M., Skinner, J. S., Ristić, A. D., Seferovic, P. M., Scott, M., Turley, S., Fuat, A., et al. (2018) · ESC Heart Failure · doi:10.1002/ehf2.12302 · Cited by 13
Self-citationPouyamehr, A., Mirhaghi, A., Sharifi, M. D., & Eshraghi, A. (2019) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.1920-8642.2019.04.004 · Cited by 14
Impacts of transit reliability on wait time: insights from AFC data
Currie, G., & Csikos, D. (2007) · Transportation Research Board 86th Annual MeetingTransportation Research Board · Cited by 13
Seheult, J. N., Stram, M. N., Contis, L. C., Pontzer, R. E., Hardy, S., Wertz, W., Baxter, C. M., Ondras, M., Kip, P. L., Snyder, G. M., et al. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00291-23 · Cited by 13
Collerton, J. C., Kingston, A., Yousaf, F., Davies, K., Kenny, A., Neely, D., Martin-Ruiz, C. M., MacGowan, G. A., Robinson, L. A., Kirkwood, T. B. L., et al. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-128 · Cited by 12
“Dyspnoea has a high sensitivity (89%) for chronic HF, although low specificity (51%) [9].”
BackgroundResultInfluentialImpact of NIHR HTA Programme funded research on NICE clinical guidelines: a retrospective cohort
Turner, S., Bhurke, S., & Cook, A. (2015) · Health Research Policy and Systems · doi:10.1186/s12961-015-0025-8 · Cited by 12
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Михайловна, Г. Е., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2020) · Eurasian heart journal · doi:10.38109/2225-1685-2020-3-6-76 · Cited by 13
Chudleigh, J. H., Chinnery, H., Holder, P., Carling, R. S., Southern, K. W., Olander, E. K., Moody, L., Morris, S., Ulph, F., Bryon, M., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-044755 · Cited by 13
Primary care providers’ role in newborn screening result notification for cystic fibrosis
Hayeems, R. Z., Miller, F. A., Barg, C. J., Bombard, Y., Chakraborty, P. K., Potter, B. K., Patton, S. J., Bytautas, J., Tam, K., Taylor, L., et al. (2021) · Canadian Family Physician · doi:10.46747/cfp.6706439 · Cited by 12
The PapilloCheck Assay for Detection of High-Grade Cervical Intraepithelial Neoplasia
Crosbie, E. J., Bailey, A. C., Sargent, A., Gilham, C., Peto, J., & Kitchener, H. C. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01578-15 · Cited by 12
Strategies to identify individuals with monogenic diabetes: results of an economic evaluation
Peters, J., Anderson, R., Shields, B. M., King, S., Hudson, M., Shepherd, M. H., McDonald, T. J., Pearson, E. R., Hattersley, A. T., & Hyde, C. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034716 · Cited by 12
Experiences of accessing obesity surgery on the NHS: a qualitative study
Owen‐Smith, A., Donovan, J., & Coast, J. (2016) · Journal of Public Health · doi:10.1093/pubmed/fdv209 · Cited by 19
Goyder, C., Roalfe, A. K., Jones, N. R., Taylor, K. S., Plumptre, C. D., James, O., Fanshawe, T. R., Hobbs, R. F., & Taylor, C. J. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14314 · Cited by 14
Self-citationNewborn screening for cystic fibrosis
Carroll, J. C., Hayeems, R. Z., Miller, F. A., Barg, C. J., Bombard, Y., Chakraborty, P. K., Potter, B. K., Bytautas, J., Tam, K., Taylor, L., et al. (2021) · Canadian Family Physician · doi:10.46747/cfp.6706e144 · Cited by 11
Qualification versus validation of biomarkers
Doust, J. A. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.493380 · Cited by 12
Self-citationRossi, P. G., Carozzi, F., Collina, G., Confortini, M., Palma, P., Lillo, M. D., Mistro, A. D., Ghiringhello, B., Gillio‐Tos, A., Maioli, P., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcp6j2oefoytrfd · Cited by 11
Rocha, B. M. L., Cunha, G., Freitas, P., Lopes, P. M., Santos, A. C., Guerreiro, S. L., Tralhão, A., Ventosa, A., Andrade, M. J., Abecasis, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99816-6 · Cited by 10
Barrios, V., Llisterri, J. L., Escobar, C., Alfaro, P., Colado, F., Ridocci, F., & Matalí, A. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.28 · Cited by 10
Park, Y. S., Park, D. J., Lee, J. H., Lee, H., Ha, T. K., Kim, Y.-J., Ryu, S.-W., Han, S.-M., Yoo, M., Park, S. S., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018044 · Cited by 10
Peeters, J. M., Wijk, S. S., Bektas, S., Knackstedt, C., Rickenbacher, P. R., Nietlispach, F., Handschin, R., Maeder, M. T., Muzzarelli, S., Pfisterer, M. E., et al. (2013) · Netherlands Heart Journal · doi:10.1007/s12471-013-0503-y · Cited by 10
“In part, this may be due to difficulties in clinical evaluation, with symptoms and signs often being vague and undiscriminating [2].”
BackgroundEvidence and Cost Effectiveness Requirements for Recommending New Biomarkers.
Collinson, P. O. (2015) · PubMed Central · Cited by 10
Expert consensus on the usefulness of natriuretic peptides in heart failure
Nessler, J., Straburzyńska‐Migaj, E., Windak, A., Solnica, B., Szmitkowski, M., Paradowski, M. T., Kaźmierczak, J., Puacz, E., & Rozentryt, P. (2018) · Kardiologia Polska · doi:10.5603/kp.2017.0020 · Cited by 10
“Przegląd systematyczny badań ukierunkowanych na ocenę poprawności diagnozy HF w podstawowej opiece zdrowotnej na podstawie obecności objawów choroby wykazał, że duszność cechuje wysoka czułość i niska swoistość, podczas gdy inne objawy o wysokiej swoistości (orthopnoe, poszerzenie żył szyjnych, obrzęki obwodowe, hepat…”
Derks, L. S. M., Wegner, I., Smit, A. L., Thomeer, H. G. X. M., Topsakal, V., & Grolman, W. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012219 · Cited by 10
McIntyre, H. F. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq201 · Cited by 10
Kelebie, M. A., Kibralew, G., Tadesse, G., Nakie, G., Ali, D., Fanta, B., Muche, M., Fentahun, S., Rtbey, G., & Takelle, G. M. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06894-1 · Cited by 9
“This inconsistency in diagnostic approaches likely contributed to the heterogeneity of the results, as these tools differ in their sensitivity and specificity for detecting metabolic syndrome components [84, 85].”
DANIELS, J. P., Walker, K. F., Bradshaw, L. E., Dorling, J. S., Ojha, S., Gray, J. W., Thornton, J., Plumb, J., Petrou, S., Madan, J. J., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087887 · Cited by 9
Validating the rigour of adaptive methods of economic evaluation
Chauhan, A. S., Sharma, D., Mehndiratta, A., Gupta, N. M., Garg, B., Kumar, A. P., & Prinja, S. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-012277 · Cited by 9
Seebacher, B., Mills, R. J., Reindl, M., Zamarian, L., Kuisma, R., Kircher, S., Brenneis, C., Ehling, R., & Deisenhammer, F. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029565 · Cited by 9
Fifteen-minute consultation: ABCDE approach to nutritional assessment in preterm infants
Embleton, N. D. (2021) · Archives of Disease in Childhood Education & Practice · doi:10.1136/archdischild-2020-320928 · Cited by 9
Soukup, T., Davis, R. E., Lopez, M. B., Healey, A., Estevao, C., Fancourt, D. E., Dazzan, P., Pariante, C. M., Dye, H., Osborn, T., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055691 · Cited by 10
Heart failure in patients with metabolic syndrome X
Olatunbosun, P. P., Hunjul, G. N. E., Patel, A., Abbas, R. H., Mody, S., Masalha, A., Mehta, S. M., Rizwan, S., Pareek, A., Jain, S., et al. (2023) · Discoveries · doi:10.15190/d.2023.1 · Cited by 9
Biomarkers in Heart Failure – Better than History or Echocardiography?
Berliner, D., Angermann, C. E., Ertl, G., & Störk, S. (2009) · Herz · doi:10.1007/s00059-009-3314-6 · Cited by 12
Fujioka, K., Mizobuchi, M., Sakai, H., Iwatani, S., Wada, K., Yoshimoto, S., & Nakao, H. (2013) · Journal of Perinatology · doi:10.1038/jp.2013.119 · Cited by 9
Behbehani, F., Ammori, B. J., New, J. P., Summers, L. K. M., Soran, H., & Syed, A. A. (2014) · QJM · doi:10.1093/qjmed/hcu060 · Cited by 11
Usefulness of Lung Ultrasound in Diagnosing Causes of Exacerbation in Patients with Chronic Dyspnea
Rogoza, K., & Kosiak, W. (2015) · Advances in respiratory medicine · doi:10.5603/piap.a2015.0083 · Cited by 9
Safety and efficacy of off-label use of ivabradine in patients with acute heart failure
Othman, K. M. S., Mostafa, M. A. R., Yosef, A. E., & Abdeltawab, A. A. (2019) · Journal of the Saudi Heart Association · doi:10.1016/j.jsha.2019.05.006 · Cited by 9
Westerlind, B., Östgren, C. J., Midlöv, P., & Marcusson, J. O. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000499671 · Cited by 10
Academic primary care: at a tipping point?
Hobbs, R. F., & Taylor, C. J. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x679543 · Cited by 10
Charman, S. J., Okwose, N. C., Groenewegen, A., Franco, A. D., Tafelmeier, M., Preveden, A., Sebastián, C. G., Fuller, A. S., Sinclair, D. R., Edwards, D., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-091793 · Cited by 11
Self-citationPepin, M. E., Gong, X., Schulze, A., & Backs, J. (2025) · EMBO Molecular Medicine · doi:10.1038/s44321-025-00343-y · Cited by 9
“The prevalence of obesity, diabetes and heart failure has exceeded epidemic proportions across Western society (Braunwald, 1997; Mant et al, 2009; Roger, 2013), accompanied by rising rates of end-organ complications such as cardiomyopathy.”
Guía mexicana de práctica clínica para el diagnóstico y el tratamiento de la insuficiencia cardiaca
López, A. A. P., Magaña-Serrano, A., Cigarroa-López, J. A., Chávez‐Mendoza, A., Mayorga-Butrón, J. L., Garaygordobil, D. A., Ivey-Miranda, J. B., Méndez-Machado, G. F., González-Godínez, H., Mora, L. F. A., et al. (2024) · Archivos de cardiología de México · doi:10.24875/acm.m24000095 · Cited by 13
Tereshchenko, S. N., Жиров, И. В., Uskach, T. M., Saidova, M. A., Sp, G., Rimskaya, E. M., Николаевна, Н. С., Narusov, O. Y., Safiullina, A. A., Tereshchenko, A. S., et al. (2024) · Eurasian heart journal · doi:10.38109/2225-1685-2024-2-6-76 · Cited by 8
Oudejans, I., Mosterd, A., Zuithoff, N. P. A., & Hoes, A. W. (2012) · Age and Ageing · doi:10.1093/ageing/afr181 · Cited by 8
Malliarou, M. M., Panagiota, K., Vasileios, T., Iokasti, P., Tsioumanis, G., Tzenetidis, N., Apostolidi, N., Axilleas, B., Apostolakis, I., & Sarafis, P. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-31986-0_40 · Cited by 8
Mejhert, M., & Kahan, T. (2014) · European Journal of General Practice · doi:10.3109/13814788.2014.908282 · Cited by 9
Demerouti, E., Manginas, A., Athanassopoulos, G. D., Karatasakis, G., Leontiadis, E., & Pavlides, G. S. (2012) · Respiratory Care · doi:10.4187/respcare.01752 · Cited by 8
S-phase–specific radiosensitization by gemcitabine for therapeutic carbon ion exposurein vitro
Harrabi, S., Adeberg, S., Winter, M., Haberer, T., Debus, J., & Weber, K. (2016) · Journal of Radiation Research · doi:10.1093/jrr/rrv097 · Cited by 8
Metadata
- Authors
- Mant, J., Doust, J., Roalfe, A., Barton, P., Cowie, M., Glasziou, P., Mant, D., McManus, R., Holder, R., Deeks, J., Fletcher, K., Qume, M., Sohanpal, S., Sanders, S., & Hobbs, F.
- Affiliations
- University of Birmingham (GB)
- Bond University (AU)
- National Institutes of Health (US)
- University of Oxford (GB)
- Corresponding author
- Mant, J
- Venue
- Health Technology Assessment
- Published
- 2009-07
- Volume
- 13
- Issue
- 32
- Pages
- 1-207, iii
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W2075669100
- Cited by
- 498
- References
- 197
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 18 · 2023: 34 · 2022: 26 · 2021: 29 · 2020: 32 · 2019: 34 · 2018: 28 · 2017: 35 · 2016: 41 · 2015: 36 · 2014: 36 · 2013: 31 · 2012: 38
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Health Technology Assessment (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Bond University Research Portal (Bond University) (submittedVersion, other-oa)
- e-publications@bond (Bond University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Health Technology Assessment programme (05/06/01)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Keywords
- heart failure diagnosis, diagnostic accuracy, dyspnea, brain natriuretic peptide, NT-proBNP, electrocardiogram, chest radiography, clinical prediction rules, cost-effectiveness, diagnostic approach, primary care, echocardiography, decision analysis, sensitivity and specificity, clinical features, edema, orthopnea, hepatomegaly
- MeSH terms
- Aged, Aged, 80 and over, Diagnosis, Differential, Female, Heart Failure, Heart Function Tests, Humans, Male, Middle Aged, Primary Health Care, State Medicine, Practice Guidelines as Topic, Natriuretic Peptide, Brain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.